Iatrogenic Kaposi sarcoma of the small bowel in Crohn's disease following short-term use of immunomodulators: a case report and review of the literature

Chia Nan University of Pharmacy & Science Institutional Repository > 行政單位 > 123 > Item 310902800/34628

請使用永久網址來引用或連結此文件: https://ir.cnu.edu.tw/handle/310902800/34628

標題:	Iatrogenic Kaposi sarcoma of the small bowel in Crohn's disease following short-term use of immunomodulators: a case report and review of the literature
作者:	Wu, Pei-Jui Sun, Chi-Shu Kuo, Hsing-Tao Sheu, Ming-Jen Lin, Cheng-Yi Wang, Su-Hung Yang, Chun-Chi Chen, Chi-Hsing Chuang, Shih-Sung Feng, I-Che
貢獻者:	Chi Mei Hospital Chi Mei Hospital Chia Nan University of Pharmacy & Science
關鍵字:	ulcerative-colitis diagnosis patient
日期:	2022
上傳時間:	2023-12-11 14:01:27 (UTC+8)
出版者:	BMC
摘要:	Background Kaposi sarcoma is a vascular tumor highly related to human herpesvirus-8 and Kaposi sarcoma-associated herpesvirus. Kaposi sarcoma usually manifests as skin or mucosal lesions; involvement in visceral organs such as the gastrointestinal tract is rare. Kaposi sarcoma can occur in immunocompromised patients receiving immunosuppressive therapy, in which case it is known as iatrogenic Kaposi sarcoma or drug-induced Kaposi sarcoma. Intestinal Kaposi sarcoma in patients with inflammatory bowel disease is extremely rare. Case presentation A 46-year-old East Asian male with recently diagnosed Crohn's disease was administered azathioprine and prednisolone; however, the patient complained of persistent abdominal pain and diarrhea following treatment. Endoscopy revealed small bowel Kaposi sarcoma. The patient was treated with systemic chemotherapy successfully without relapse. Conclusions This is the fifth case of Kaposi sarcoma developed over the small intestine in a patient with Crohn's disease following administration of immunomodulators. Additionally, this case indicated that even short-term immunomodulator use can induce Kaposi sarcoma in patients with inflammatory bowel disease. Thus, in patients with inflammatory bowel disease, if symptoms are aggravated or do not abate after immunomodulators prescription, and before intending to upgrade immunomodulators, endoscopy should be considered. Finally, chemotherapy can also be considered if both medication withdrawal and surgical intervention are not feasible.
關聯:	JOURNAL OF MEDICAL CASE REPORTS, v.16, n.CB2, pp.CC2, pp.-2518,
顯示於類別:	[行政單位] 123

文件中的檔案:

檔案	描述	大小	格式	瀏覽次數
index.html		0Kb	HTML	104	檢視/開啟

在CNU IR中所有的資料項目都受到原著作權保護.

TAIR相關文章

資料載入中.....